Profiteering Laws Fail Prostate Cancer Patients

Nov. 6 (Bloomberg) -- At up to $40,000 per patient, intensity-modulated radiation therapy, or IMRT, is one of the most profitable prostate cancer treatments for urologists, while not necessarily the most effective, according to several medical studies. One in five urologists now boost their income by billing for the therapy, according to a survey by the Urology Times. Bloomberg's Kevin Thrash reports on some urologists in Monterey County, California, who are being investigated by U.S. Department of Health and Human Services for possibly putting profits ahead of patients. (Source: Bloomberg)
Operation Charlie Foxtrot: David Rothkopf
54:18 - On “Morning Must Read,” Bloomberg’s Olivia Sterns recaps the op-ed pieces and analyst notes that provide insight into today's headlines. Foreign Affairs Editor Gideon Rose also speaks on “Bloomberg Surveillance.” (Source: Bloomberg)
  • An Insider’s View of Nigerian Elections
  • Debt Could Derail China’s Ambitions: William Pesek
  • U.S. Housing Market Not Normal Yet: Nationwide’s Berson